Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-high resolution multimodal MRI densely labelled holistic structural brain atlas.

Scientific reports·2026
Same author

petBrain: a new pipeline for amyloid, Tau tangles and neurodegeneration quantification using PET and MRI.

Alzheimer's research & therapy·2025
Same author

Robust deep MRI contrast synthesis using a prior-based and task-oriented 3D network.

Imaging neuroscience (Cambridge, Mass.)·2025
Same author

Lifespan Tree of Brain Anatomy: Diagnostic Values for Motor and Cognitive Neurodegenerative Diseases.

Human brain mapping·2025
Same author

Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan.

Brain : a journal of neurology·2025
Same author

DeepCERES: A deep learning method for cerebellar lobule segmentation using ultra-high resolution multimodal MRI.

NeuroImage·2025

Related Experiment Video

Updated: Jul 18, 2026

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Brain structure ages-A new biomarker for multi-disease classification.

Huy-Dung Nguyen1, Michaël Clément1, Boris Mansencal1

  • 1Univ. Bordeaux, CNRS, Bordeaux INP, LaBRI, UMR 5800, Talence, France.

Human Brain Mapping
|January 15, 2024
PubMed
Summary

This study introduces brain structure age estimation from MRI scans, improving upon global brain age predictions. This novel biomarker aids in detecting population-level anomalies and diagnosing neurological diseases at the individual level.

Keywords:
Alzheimer's diseaseParkinson's diseaseage predictionbrain structure agesdeep learningfrontotemporal dementiamulti-disease classificationmultiple sclerosisschizophrenia

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.2K

Related Experiment Videos

Last Updated: Jul 18, 2026

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.2K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Neurology

Background:

  • Chronological age is a key factor in brain anatomy and aging.
  • Deviations from normal brain aging trajectories may indicate neurological diseases.
  • Current brain age gap metrics are insufficient for detailed disease classification.

Purpose of the Study:

  • To extend global brain age estimation to individual brain structure ages using structural MRI.
  • To develop a novel biomarker for anomaly detection and differential diagnosis of neurological conditions.
  • To enhance the clinical utility of neuroimaging in understanding brain aging and disease.

Main Methods:

  • Utilized an ensemble of deep learning models to generate a 3D voxel-wise aging map from structural MRI.
  • Employed 3D segmentation masks to derive specific brain structure ages.
  • Validated the approach for population-level anomaly detection and subject-level disease classification.

Main Results:

  • The proposed method for estimating brain structure ages outperforms existing state-of-the-art approaches in anomaly detection.
  • Brain structure age deviations provide a powerful feature for multi-disease classification and differential diagnosis.
  • Visualizations of individual brain structure age deviations offer clinical insights into brain abnormalities.

Conclusions:

  • Brain structure age estimation offers a more informative biomarker than global brain age for neurological disease analysis.
  • This approach enhances anomaly detection at the population level and differential diagnosis at the subject level.
  • The developed biomarker has significant potential to aid clinicians in medical contexts by visualizing brain abnormalities.